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INTRODUCTION
Most structural abnormalities detected in prenatal diagno-
sis are generally familial inheritances (1, 2). The risk of phe-
notypic abnormality is very low when balanced chromosome
rearrangement is inherited from a phenotypic normal carrier
parent (2, 3). However, unbalanced rearrangements are like-
ly to be associated with abnormal phenotypes because of dele-
tion, duplication, or both (4). The incidence of de novo bal-
anced reciprocal translocation is 1/2,000 and de novo balanced
Robertsonian translocation is 1/10,000. Also, it has been
reported that the risk of phenotypic abnormality is 6-7% for
de novo reciprocal translocation and 3.7% for de novo Robert-
sonian translocation (5-7). Even a de novo balanced transloca-
tion on prenatal test could result in phenotypic abnormali-
ties, possibly due to microdeletion adjacent to the breakpoint,
undetected small deletions, gene disruption, or positional
effects (8). Therefore, the interpretation and counseling on
de novo chromosome rearrangements in prenatal diagnosis,
compared with familial inheritance, is more difficult (3, 7).
Accurate diagnosis and follow-up studies are important for
genetic counseling on de novo chromosome rearrangements.
Here, we report our experiences of 17 cases of de novo chro-
mosome rearrangements detected in the prenatal diagnosis.
MATERIALS AND METHODS
Prenatal cytogenetic analyses were performed in 5,501
pregnancies at Samsung Cheil Hospital from 1995 to 1999.
Indications for cytogenetic analysis included advanced mater-
nal age, elevated maternal serum AFP levels, abnormal ultra-
sound findings, parental chromosome abnormalities, previ-
ous history of abnormal chromosome, family history of genet-
ic disease, and other reasons. Specimens for cytogenetic anal-
ysis were obtained by amniocentesis, chorionic villi sampling,
and cordocentesis. Preparation and analysis of chromosomes
for karyotyping were performed using the usual GTG-band-
ing method (9). The parents'chromosomes were analyzed in
order to determine whether the abnormality found in the fetus
was de novo or inherited. If the fetus was found to have de
novo chromosome rearrangements, special techniques such
as high-resolution banding, RBG banding, C-banding, NOR-
banding, and FISH or CGH were applied for identification
and characterization of abnormal chromosomes (9). We re-
viewed the obstetrical records with fetal ultrasound results
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The aim of this study was to examine the incidence and clinical outcome of de
novo chromosomal aberrations retrospectively and provide useful data for
genetic counseling in the prenatal cytogenetic diagnosis. We found 17 cases of
de novo chromosomal aberrations in 5,501 cases of prenatal cytogenetic analy-
sis and reviewed the karyotype, further study, medical records, fetal ultrasound
findings and clinical outcomes. Out of the 17 de novo chromosomal aberrations,
5 had balanced reciprocal translocations and 12 had unbalanced translocations
characterized as deletion, addition, or marker. In the case of the five balanced
reciprocal translocations, 3 cases without abnormal ultrasound findings were
carried to term after comprehensive genetic counseling. Neonates were pheno-
typically normal and clinical examinations were normal. Two cases with abnor-
mal ultrasound findings were terminated therapeutically. Twelve cases of unbal-
anced translocations were terminated except one case with a mosaic marker
chromosome. High resolution fetal ultrasound and detailed cytogenetic and
molecular study will be adjunctive tools for predicting the karyotype/phenotype
correlations of fetuses with de novo chromosomal aberrations, although they
have limitation to find all phenotypic effects.
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and clinical outcomes in 17 cases.
RESULTS
Seventeen de novo chromosome rearrangements were iden-
tified from 5,501 prenatal cytogenetic diagnoses. There were
chromosome rearrangements with balanced reciprocal translo-
cation in 5 cases and unbalanced chromosome rearrangements
with deletion, addition, and marker chromosome in 12 cases
(Table 1). Indications for chromosome analysis in 17 cases
with de novo chromosome rearrangements were abnormal
findings at fetal screening sonography in 9 cases, advanced
maternal age in 4, and maternal serum screening positive in
4 (Table 1). 
Ultrasound findings were not remarkable in 4 fetuses with
unbalanced aberrations (case 1-4) (Table 2). Clinical abortions
were performed at the request of both parents’ for case 1 with
deletion in the long arm of chromosome 18 and case 2 with
Down syndrome caused by translocated chromosome 21. Of
the two cases with a mosaic marker chromosome, case 3
showed negative results on both C-banding and NOR-band-
ing. Although the fetus was known to have normal findings
in high resolution fetal sonographic examination, the preg-
nancy ended in clinical abortion at the parents’request with-
Anomaly at fetal 
screening sonography 1 8 9
Advanced maternal age 3 1 4
Maternal serum 
screening positive 1 3 4
Total 5 12 17
Indication Balanced Unbalanced Total
Table 1. Indications for chromosome analysis and types of chro-
mosomal rearrangement in 17 pregnancies with de novo chro-
mosome rearrangements
Unbalanced
1 46,XX,del(18)(q21) AMA Normal TOP
2 46,XY,inv(9),der(14;21) MSS + Normal FISH; D21S65x3* TOP
(q10;q10),+21
3 47,XY,+mar/46,XY MSS + Normal C-banding (-), TOP
NOR-banding (-)
4 47,XY,+mar/46,XY MSS + Normal C-banding (-),  Normal
NOR-banding (+), birth
CGH; Normal
5 46,XX,add(4)(q35) Ab-US Hydrops fetalis FISH; wcp4+ TOP
6 46,XX,add(13)(q32) Ab-US IUGR, Oligohydramnios TOP
7 46,XY,del(4)(p15.2) Ab-US IUGR, Diaphragmatic hernia FISH; D4S96- TOP
8 46,XX,del(4)(p15) Ab-US IUGR, Coarctation of aorta, FISH; D4S96- TOP
Cystic hygroma
9 46,XX,del(5)(p15.2) Ab-US Dolichocephaly, FISH;  D5S23- TOP
Oligohydramnios
10 46,XY,del(13)(q?21) Ab-US Duodenal atresia, TOP
Polyhydramnios
11 46,XY,del(20)(p13) Ab-US Hydronephrosis CGH; dim(20p13) TOP
12 45,XX,dic(15;18) Ab-US Increased nuchal translucency FISH; D15Z1+, TOP
(p11.2;p11.1) (5 mm at 13 wks) D18Z1+, D18S552-
CGH; dim(18p11.1) 
Balanced
13 46,XX,t(2;21)(q11.1;q22.3) AMA Normal HR, RBG Normal
FISH; D21S65x2 birth
14 46,XY,t(10;19)(p11.2;p12) MSS + Normal FISH; wcp19+; Normal
wcp19+ to 3 yrs
15 46,XY,t(3;7)(q25;p15) AMA Normal HR, RBG Normal
to 5 yrs
16 46,XX,t(2;4)(q23;q28) Ab-US Heart anomaly RBG TOP
17 46,XX,t(8;20)(q24.2;q12) AMA Lemon-shaped skull, HR TOP
Ventriculomegaly, 
Thickened myocardium, 
Micrognathia
AMA; advanced maternal age, TOP; termination of pregnancy, MSS +; maternal serum screening positive, Ab-US; abnormal ultrasound findings, HR;
high resolution GTG-banding, RBG; reverse bands by BrdU using Giemsa, *; Three copies of locus 21q22,  ; Loss of region from 20p13 to 20pter.
Cases Karyotype Indication Ultrasound findings Further studies Outcome
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out additional experiments. For another fetus with marker
mosaicism, case 4, the marker chromosome was revealed to
have originated from satellites by special banding techniques
such as NOR-banding and C-banding and there was no gain
of genomic DNA using CGH. The pregnancy was allowed
to continue until the delivery at term and the baby was phe-
notypically normal. 
Unbalanced rearrangements were detected in 8 fetuses with
abnormal ultrasound findings (case 5-12). In case 5, it was
revealed that the additional material of the long arm of chro-
mosome 4 had originated from chromosome 4 by FISH with
painting probes for chromosome 4 (Fig. 1A). Case 6 had
severe intrauterine growth retardation (IUGR) and oligohy-
dramniosis at 25 weeks. Cord blood karyotype was 46,XX,
add(13)(q32). Autopsy showed perimembranous ventricular
septal defect. In case 7, 8, and 9, deletions of the short arm of
chromosome 4 or chromosome 5 were confirmed using locus-
specific probes for identification of deletions of chromosome
band 4p16.3 and band 5p15.2, respectively. Case 10 had poly-
hydramnios and duodenal atresia on ultrasound. In case 11
where it was difficult to determine the deleted arm using the
routine G-banding method, it was concluded that the short
arm of chromosome 20 had a partial deletion by CGH. Case
12 showed increased nuchal translucency at 13 weeks of gesta-
tion, the fetus was confirmed to have a dicentric chromosome
for chromosomes 15 and 18 and partial deletion of the short
arm of chromosome 18 by FISH and CGH (Fig. 1B). Autopy
showed no gross anomaly.
Fig. 1. Characterization of abnormal chromosomes detected on
prenatal diagnosis. FISH analysis using whole chromosome paint-
ing probes for chromosome 4 in case 5 reveals that the origin of the
added material was chromosome 4 (A). FISH using the telomeric
probes for the short arm of chromosome 18 (D18S552) and the
centromeric probes for chromosome 18 (D18Z1) in case 12 showes
that the dic(15;18) harbored the centromeric part of chromosome
18 but not the 18p telomere region (B). RBG banding for balanced
translocation between chromosome 2 and chromosome 21 reveals
that the breakpoints occurred at 2q11.1 and 21q 22.3 (C).
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Out of the five fetuses with de novo balanced rearrange-
ments, three fetuses (cases 13, 14, and 15) showed normal
ultrasound findings and were born normal (Fig. 1C). How-
ever, two fetuses had abnormal findings on sonographic exam-
ination. The karyotype of case 16 was 46,XX,t(8;20) (q24.2;
q12) and the fetus showed abnormal ultrasound findings
such as lemon-shaped skull, borderline asymmetric dilatation
of lateral ventricles of the head, thickened myocardium, and
suspicious micrognathia. The karyotype of case 17 was 46,
XX,t(2;4)(q23;q28) and the fetus had a heart anomaly on
sonography. In both cases the pregnancy was discontinued
at the parents’ request and autopsy finding was consistent
with prenatal ultrasound.
DISCUSSION
Among the de novo chromosome rearrangements detected
in prenatal diagnosis, most fetuses with unbalanced rearrange-
ments showed morphologically abnormal findings (10-12).
Hume et al. reported that fetal anomalies were detected by
ultrasonography in 45% of cases of de novo structural rear-
rangement, and that there was a statistically significant in-
crease in the incidence of fetal anomaly detection compared
with familial balanced rearrangements or cytogenetic poly-
morphisms (13). In our study, no anomaly was observed on
follow-up ultrasonography in four cases carrying the unbal-
anced rearrangement. Because of the parents’ anxiety for
abnormal phenotypes due to chromosome aberrations, three
cases were terminated. One case with marker mosaicism was
continued the pregnancy.
Cytogenetic analyses were referred in 8 of the 12 cases with
unbalanced rearrangements due to anomalies detected on fetal
screening sonography examination. Particularly, we confirmed
that the deleted regions did not translocate to the other chro-
mosomes by FISH in the cases 7 and 8 with deletions with-
in the short arm of chromosome 4. And both had typical an-
omalies of Wolf-Hirschhorn syndrome such as intrauterine
growth retardation, diaphragmatic hernia, and heart defects
(14).
Chromosomal study was performed due to the increased
nuchal translucency at 13 weeks of gestation  in the case 12.
We could find that there were centromere regions both in
the chromosome 15 and 18. We concluded that the fetus had
monosomy for the short arm of chromosome 18 using cen-
tromeric probes and subtelomeric probe. 
Of five cases with balanced chromosomal abnormalities,
two had fetal ultrasonographic dysmorphological character-
istics. Especially, it was suspected that ultrasonographic an-
omalies such as ventriculomegaly and lemon sign in case 17
were most likely to be associated with a chromosomal
abnormality (15).
Molecular cytogenetic techniques have been known as pow-
erful methods for identification of complex or cryptic chro-
mosomal rearrangements in prenatal diagnosis. There have
been many reports that they would exactly identify and local-
ize the chromosomal rearrangement (16-18). In addition,
cytogenetic analysis followed by FISH studies made it pos-
sible for identification of small de novo structural anomalies
and marker chromosomes unidentifiable by G-banding.
Furthermore, it could give much better insights to the rela-
tion between genotype and phenotype and results using FISH
provided a much better understanding for fetal anomalies
(19-21).
Of the 5 de novo balanced chromosome rearrangements,
we could not exclude the possibility of a submicroscopic dele-
tion or a gene disruption at the breakpoint in two cases with
ultrasonographic fetal anomaly. Resampling was undertak-
en for the three cases with balanced translocation and normal
ultrasound findings. Additional experiments were carried out
using painting probes or locus-specific probes and by special
banding techniques such as high-resolution GTG banding
and RBG-banding to identify the cytogenetic abnormalities
more precisely.
In apparently balanced translocation cases, counseling and
prediction of outcome is difficult because of the paucity of
long term outcome data and diagnostic tools for the normal-
ity. Many clinicians have tried to expect the karyotype-phe-
notype correlation with ultrasound in abnormal chromoso-
mal cases. In our de novo balanced translocation series, two
out of five were diagnosed fetal cardiac abnormalities by ultra-
sound and confirmed pathologically. The others with no gross
anomaly on fetal ultrasound were continued and delivered
grossly healthy babies and showed normal physical and men-
tal development until now. Although fetal ultrasound has
limitation to find all anatomical anomalies and functional
disabilities, detailed fetal ultrasound evaluation including
echocardiography is very helpful in prediction of the progno-
sis of de novo balanced translocation cases. And more cases
with long term follow up data are needed to establish the
optimal management protocol.
In the present study, for the cases detected as having de novo
chromosome abnormalities, we confirmed the rearrangements
additionally using a different type of available fetus cells and
performed FISH or CGH and special banding techniques such
a high-resolution banding, NOR-banding, C-banding, or
RBG-banding, in order to elucidate the characteristics of
chromosomes more clearly. The more precise identification
of these de novo chromosome abnormalities can play an impor-
tant role in genetic counseling and decision-making in pre-
natal diagnosis.
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